This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 24Jan 2017

    Antoni van Leeuwenhoek Prize 2016 for Fabricio Loayza-Puch

    Cancer researcher Fabricio Loayza-Puch has received this year's Antoni van Leeuwenhoek Prize (AvL prize). The AvL prize is awarded each year to one of the most highly talented young researchers of the Netherlands Cancer Institute (NKI). Loayza-Puch received the prize because he developed a technique to detect metabolic vulnerabilities of tumors.

    Read More
  • 18Jan 2017

    Martijn Stuiver appointed as lector at the Amsterdam University of Applied Sciences

    NKI employee Martijn Stuiver, physiotherapist in our clinic and researcher in the field of supportive care and revalidation after cancer, has been appointed as lector at the Amsterdam University of Applied Sciences. He will hold this position for one day a week in the next five years. He will also continue with his work in the Netherlands Cancer Institute.

    Read More
  • 13Jan 2017

    Thesis defense of Philip Schouten

    How can we improve the treatment of patients with a BRCA1 or BRCA2 mutated tumor? That was the central question behind the PhD research of Philip Schouten. He will defend his thesis on January 17.

    Read More
  • 12Jan 2017

    NKI researchers identify protein that is essential for infection by picornaviruses

    Jacqueline Staring, a member of the laboratory of Thijn Brummelkamp, has discovered that once picornaviruses are attached to the cell a single human host cell protein assists their further entry. This offers promise for future antiviral therapies. The discovery was published in Nature on January 11.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2014 542
Total impact of publications in 2014 3712
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page